Your session is about to expire
← Back to Search
Bevacizumab for Breast Cancer
Study Summary
This trial is studying a combination of drugs as a possible treatment for triple-negative breast cancer.
- Breast Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What potential complications are associated with the administration of Bevacizumab?
"While there is some evidence of Bevacizumab's safety, no studies have yet confirmed its efficacy. Thus, our team has rated it a 2 on the scale from 1 to 3."
To what medical conditions is Bevacizumab regularly prescribed?
"Bevacizumab is commonly prescribed to treat recurrent platinum drug resistant primary peritoneal cancer, and can also be used in the management of other illnesses such as neoplasm metastasis, recurrent non-squamous non-small cell lung cancer, neuroendocrine tumors."
Have any other experiments been conducted using Bevacizumab as a treatment?
"Bevacizumab is presently being tested in 800 trials, 223 of which are currently at Phase 3. Most clinical tests for Bevacizumab occur in Bethesda, Maryland; however altogether there exist 42271 locations running studies with this therapeutic agent."
Are recruitment efforts still underway for this research project?
"Data hosted on clinicaltrials.gov affirms that this trial is not currently employing new patients; the study was initially published on December 1st, 2016 and last amended on August 18th 2022. However, there are 5358 other medical studies presently enrolling participants."
Is this endeavor a novel approach to the issue?
"Research into bevacizumab began in 1997 with a study sponsored by Alfacell, involving 300 participants. Subsequent Phase 3 approval was granted and there are now 800 extant experiments being conducted across 2588 cities and 74 countries worldwide."
How many individuals have been accepted into this experiment?
"Unfortunately, this clinical trial is no longer enrolling patients. It was initially posted on December 1st 2016 and last updated in August 18th 2022. If you are considering other medical trials, there are currently 4558 studies actively recruiting for carcinoma treatments as well as 800 trials using bevacizumab recruiting participants."
Share this study with friends
Copy Link
Messenger